412 related articles for article (PubMed ID: 8395548)
1. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
2. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
MacNeil D; Fraga E; Singh B
Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
[TBL] [Abstract][Full Text] [Related]
4. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
Abe R; Foo-Phillips M; Granger LG; Kanagawa O
J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
[TBL] [Abstract][Full Text] [Related]
6. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
Okamoto M; Kimura S; Katagiri M
Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
8. Physiologic expression of two superantigens in the BDF1 mouse.
Gollob KJ; Palmer E
J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
[TBL] [Abstract][Full Text] [Related]
9. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
[TBL] [Abstract][Full Text] [Related]
10. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
[TBL] [Abstract][Full Text] [Related]
11. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
12. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
Beutner U; McLellan B; Kraus E; Huber BT
Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
[TBL] [Abstract][Full Text] [Related]
13. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
15. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma.
Blank U; Boitel B; Mège D; Ermonval M; Acuto O
Eur J Immunol; 1993 Dec; 23(12):3057-65. PubMed ID: 8258318
[TBL] [Abstract][Full Text] [Related]
16. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
[TBL] [Abstract][Full Text] [Related]
17. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
18. Conserved amino acid residues in the complementarity-determining region 1 of the TCR beta-chain are involved in the recognition of conventional Ag and Mls-1 superantigen.
Kang J; Chambers CA; Pawling J; Scott C; Hozumi N
J Immunol; 1994 Jun; 152(11):5305-17. PubMed ID: 8189048
[TBL] [Abstract][Full Text] [Related]
19. A stimulatory Mls-1 superantigen is destroyed by ultraviolet light while other Mtv-7 antigens remain intact. Significance for Mls-1 unresponsiveness.
Dannecker G; Mecheri S; Clarke K; Dudhane A; Wang ZQ; Hoffmann MK
J Immunol; 1992 Dec; 149(11):3463-7. PubMed ID: 1331237
[TBL] [Abstract][Full Text] [Related]
20. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
Borrero H; Collazo L; Macphail S
Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]